Purpose
to evaluate the safety of oral polio vaccine (OPV) by monitoring the incidence of vaccine-associated paralytic poliomyelitis (VAPP) in China, and to provide useful genomic & bio-feature information for developing a safer OPV
Grantee
Division
Global Development
Date
OCTOBER 2012
Region served
ASIA
Committed amount
$1,068,783
Grant topic
Polio
Duration (months)
22
Grantee location
Beijing, Beijing Shi, China
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.